The CTD dossier owner and manufacturer, founded in 1994, is a high-tech enterprise focusing on the global health industry, particularly in biopharmaceuticals and biomedical engineering. It offers a range of products, including prescription medications, over-the-counter drugs, medical devices, and supplements, with key therapeutic areas in cardiocerebrovascular health, digestion and metabolism, tumor immunity, and neuroscience. The company has pioneered international research efforts, notably in Traditional Asian Medicine, with its flagship product undergoing FDA-approved clinical trials. It emphasizes innovation in integrated medicine and personalized health solutions, leveraging advanced technologies like AI and big data for global impact. The company holds several GMP certifications and has patents for its product innovations. They have a strong track record, consistently ranking among the top pharmaceutical companies in Asia and receiving recognition for their contributions to poverty alleviation and scientific advancements in tradicional medicine. Their operations span multiple regions, including the EU and North America.